Business   

Biological's plans

By Our Special Correspondent

HYDERABAD DEC. 9. The 50-year-old Biological E Ltd, the country's first private sector biological products company has forayed into biotechnology and is making an investment of Rs. 100 crores in Phase I in a modern biotech project fast coming up on a 50 acre site in the Biotech Park 40 km from here. The Phase I is scheduled to be completed by December 2004.

Announcing this at a press conference here on Tuesday, Mahima Datla, Vice-President, Strategic Business Development, said the new facility would be used to produce other vaccines like Hepatitis B and `Combination vaccines' for paediatrics. It also plans to launch the HIB vaccine.

Deepak Sarda, Senior Vice-President, said with the committed investment in the new biotech project, the company would be banking heavily on biotechnology capabilities.

Printer friendly page  
Send this article to Friends by E-Mail

Business

News: Front Page | National | Southern States | Other States | International | Opinion | Business | Sport | Miscellaneous |
Advts: Classifieds | Employment | Obituary |

Stories in this Section

• RBI asks banks to improve risk management
• CMIE revises forecast
• IBA to take up 'Vision 2010' report
• Philips to close down lamp facility
• Reliance MF launches MIP
• Rupee ends higher
• Sensex recovers 98 points
• EGL India operations
• Aviation set for the real take-off: CII
• Nicholas' pact with U.S. firm
• UTI MF declares 100 p.c. dividend under two plans
• Regulatory framework for NGOs and SHGs
• Biological's plans
• Aircel to expand network
• Sanmar group acquires biotech firm
• Chennai Petroleum renames CBR oil jetty
• ISO for Apollo's First Med Hospitals
• ABN Amro launches trade portal
• NLC bags award
• Stock Market Index
• Exchange rates
• Bullion rates
• BECON on Dec. 11
• Eicher demerger move
• Ban on Snowcem

Copyright © 2003, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu